Medicxi Ventures Management (Jersey)
ST. HELIER, Y9files as Medicxi Ventures Management (Jersey) Ltd
$177m in 3 US stocks at the end of 30 June 2026. The top 10 are 100.0% of the money. It changed about 80.8% of the portfolio this quarter.
Value
$177m
Stocks
3
Top 10 share
100.0%
Turnover
80.8%
What changed this quarter
New
Bought for the first time this quarter.
None this quarter.
Added
Bought more of a stock they already held.
None this quarter.
Cut
Sold some of their stake.
- NewAmsterdam PharmaNAMS42.2% of the fund-17%
Sold out
Sold their entire stake.
- Centessa Pharmaceuticals-100%
Holdings
| Company | Share of fund | Value | Shares | Change |
|---|---|---|---|---|
| Phathom PharmaceuticalsPHAT | 45.6% | $81m | 7,464,572 | Held |
| NewAmsterdam PharmaNAMS | 42.2% | $75m | 2,208,639 | -17% |
| Aura BiosciencesAURA | 12.2% | $22m | 3,039,892 | Held |
Over time and by industry
Value over time
Jun '25
Dec '25
Jun '26
Value is down 58.5% since 30 June 2025.
Where the money is
Health care100.0%
From the fund's 13F filings. They list US stocks and options only, 45 days after each quarter, and leave out cash, bonds, shorts and foreign shares.